These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15830334)

  • 21. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.
    de la Lastra CA; Villegas I
    Mol Nutr Food Res; 2005 May; 49(5):405-30. PubMed ID: 15832402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of resveratrol on atherosclerosis.
    Fan E; Zhang L; Jiang S; Bai Y
    J Med Food; 2008 Dec; 11(4):610-4. PubMed ID: 19053850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells.
    Chao HH; Juan SH; Liu JC; Yang HY; Yang E; Cheng TH; Shyu KG
    Eur J Pharmacol; 2005 May; 515(1-3):1-9. PubMed ID: 15878161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol, a phenolic antioxidant with effects on blood platelet functions.
    Olas B; Wachowicz B
    Platelets; 2005 Aug; 16(5):251-60. PubMed ID: 16011975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.
    Rosenfeld ME
    Z Kardiol; 2000; 89 Suppl 7():2-6. PubMed ID: 11098552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of resveratrol and other wine polyphenols on vascular function: an update.
    Gresele P; Cerletti C; Guglielmini G; Pignatelli P; de Gaetano G; Violi F
    J Nutr Biochem; 2011 Mar; 22(3):201-11. PubMed ID: 21111592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular effects of resveratrol in skeletal muscle.
    Dirks Naylor AJ
    Life Sci; 2009 May; 84(19-20):637-40. PubMed ID: 19233212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects.
    Lançon A; Kaminski J; Tili E; Michaille JJ; Latruffe N
    J Agric Food Chem; 2012 Sep; 60(36):8783-9. PubMed ID: 22571175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of cardiovascular protection by resveratrol.
    Hao HD; He LR
    J Med Food; 2004; 7(3):290-8. PubMed ID: 15383221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraoxonases role in the prevention of cardiovascular diseases.
    Rosenblat M; Aviram M
    Biofactors; 2009; 35(1):98-104. PubMed ID: 19319852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oxidized lipoproteins and atherogenesis].
    Jürgens G; Chen Q; Ledinski G; Kager G; Hammer A; Esterbauer H
    Acta Med Austriaca; 1993; 20(4):85-9. PubMed ID: 8237282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol and health--a comprehensive review of human clinical trials.
    Smoliga JM; Baur JA; Hausenblas HA
    Mol Nutr Food Res; 2011 Aug; 55(8):1129-41. PubMed ID: 21688389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol and chemoprevention.
    Goswami SK; Das DK
    Cancer Lett; 2009 Oct; 284(1):1-6. PubMed ID: 19261378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy.
    Kaplan M; Aviram M; Hayek T
    Pharmacol Ther; 2012 Nov; 136(2):175-85. PubMed ID: 22890211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol in cardiovascular health and disease.
    Petrovski G; Gurusamy N; Das DK
    Ann N Y Acad Sci; 2011 Jan; 1215():22-33. PubMed ID: 21261638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases.
    Mitjavila MT; Moreno JJ
    Biochem Pharmacol; 2012 Nov; 84(9):1113-22. PubMed ID: 22858365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells.
    Bruedigam C; Eijken M; Koedam M; Chiba H; van Leeuwen JP
    J Mol Cell Cardiol; 2011 Nov; 51(5):862-71. PubMed ID: 21816156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
    Benavente-García O; Castillo J
    J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.